Background: Individuals with severe generalized recessive dystrophic epidermolysis bullosa
INTRODUCTION

3
Type VII collagen (Col7) is the major component of anchoring fibrils, structures anchoring the skin epidermis to the dermis, important in wound healing and as a barrier to epithelial cancer invasion [1, 2] . In RDEB, a genetic skin disease characterized by blistering, scarring and aggressive SCC, expression of Col7 and anchoring fibrils are greatly decreased [3, 4] . Data from a Ras/IκBα-driven tumorigenesis model suggested that the noncollagenous (NC1) domain of Col7 was necessary for tumor formation by RDEB keratinocytes [5] . However, some RDEB tumors do not have Col7 expression [6] . We have previously shown, by transient KD of Col7 in a 3D model, that loss of Col7 promotes SCC invasion and disorganized differentiation in vitro [7] . Two recent studies have established that Col7 directly regulates the dermal extracellular matrix (ECM) composition in RDEB [8, 9] .
Expression of Col7 is regulated by TGF at the transcriptional level [10, 11] and, in a hypomorphic mouse model of RDEB (10% Col7) expression of dermal active TGF1 is enhanced [12] . TGF is known to promote epithelial-mesenchymal transition (EMT) and induce angiogenesis [13] . Binding of TGF activates TGFreceptor II (TRII) which then recruits and phosphorylates TGF receptor I (TRI) [14] . Latent TGF1 is activated by v6 integrin for presentation to TGF receptors [15] . Conversely, TGF1 induces expression of v6 integrin in keratinocytes [16] . The v6 integrin plays a critical role in promoting TGF-dependent EMT
[17] and invasion [18, 19] .
In the current study, we developed stable Col7 knock-down SCC cells and performed xenografts of 3D cultures in SCID nude mice to establish the effect of loss of Col7 in SCC in vivo.
We found that loss of Col7 enhances angiogenesis in SCC in mouse xenografts, RDEB skin and SCC tumors. Increased tumor angiogenesis was reversed by human recombinant Col7 protein therapy in both mouse and zebrafish xenograft models. Blocking the interaction between 21 4 integrin and Col7 enhanced TGF signaling. Increased TGF signaling was observed in RDEB tumors compared to sporadic SCC. Inhibition of TGF receptor signaling resulted in decreased endothelial cell tube formation and decreased VEGF secretion. These data suggest that Col7 acts as a tumor suppressor by reducing TGF signaling to inhibit angiogenesis.
MATERIALS AND METHODS
Patients
The use of anonymized, archival human tumor specimens was conducted according to the Declaration of Helsinki principles and approved by the appropriate local ethics committees.
Ethical regulations
All animal experiments were performed in accordance with UK Home Office regulations and the European Legal Framework for the protection of animals used for scientific purposes (European Directive 86/609/EEC).
Antibodies and recombinant proteins
The rabbit polyclonal anti-Col7 antibody was purified as described before [20, 21] . Antibodies used in this work are described in Supplementary Table 1, available online. Human recombinant full-length type VII collagen protein (hrCol7) was purified as described previously [21] . Mouse type IV collagen protein (Col4) was purchased from BD Biosciences.
Fluorescence and DAB immunostaining Archival skin sections were obtained of formalin-fixed and paraffin-embedded human RDEB and non-EB SCCs (Supplementary Table 3 , available online). Tissue microarray blocks were generated previously from RDEB and non-EB SCC [22] .
Immunostaining is described in the Supplementary Methods, available online.
In vitro epidermal models 5 Organotypic cultures on collagen:matrigel gels were performed as previously described with some modifications (Supplementary Methods, available online) [23] .
Xenografting of collagen:matrigel gels onto hairless SCID mice
For xenografting of collagen:matrigel gels in mice, in vitro organotypic cultures on collagen:matrigel gels with shCOL7, shCOL4 and shC cells were performed as described above.
After a 7 day incubation period in vitro, collagen:matrigel gels were xenografted subcutaneously onto hairless SCID Crl:SHO-Prkdc scid Hr hr mice (four replicates per condition). Mice were sacrificed after 6 weeks, and gels (including surrounding fibrotic tissue and tumors formed) were excised, cut in half, and either snap frozen or fixed in formal saline for histological analysis.
Treatment with hrCol7 was performed by injecting 30 g of hrCol7 (or PBS as a control) using a 30-gauge needle around the edge of the implanted gel at day 7 and 21 post-implantation. Seven replicates per condition were performed.
In vitro HUVEC tube formation assay
An endothelial cell tube formation assay in Matrigel was performed as described in the Supplementary Methods, available online.
Human angiogenesis proteome array
A Proteome Profiler™ Human Angiogenesis Antibody Array (R&D Systems, UK) was used to detect expression of angiogenesis-related proteins in shC and shCOL7 SCC-IC1 cells as described in the Supplementary Methods, available online.
siRNA transfection
For TRI and TRII knock-down, the EB3K cell line was transfected with a SMARTpool of four synthetic siRNAs (Dharmacon, UK), targeting TRI or TRII (Supplementary Table 2 , available online). Cells were plated at 50-60% confluency and transfected with 4 g of DharmaFECT1 6 (Dharmacon, UK) transfection reagent and 12.5 nM final concentration of each siRNA. TGFBR1
and TGFBR2 mRNA expression were analyzed by qRTPCR three days post-transfection. Cells incubated with a pool of non-targeting siRNAs (siC) were used as a negative control.
FACS labelling of 2 integrin in SCC and 2 integrin inhibition
Labelling of the 2 integrin receptor by FACS and use of a neutralizing antibody are described in the Supplementary Methods, available online.
TGF-dependent reporter assay
Cells were co-transfected with CAGA12-Luciferase (containing Smad binding elements [SBE] ) and pRenilla (pRr-TK)
[24] at a 10:1 ratio using Fugene 6 (Promega, UK). After 24 hours, transfected cells were stimulated for 18 hours with 2 ng/ml TGF1. Luciferase and Renilla luminescence was read using a Dual Luciferase reporter assay kit (Promega, UK) following the manufacturer's instructions. Luciferase was normalized to the Renilla control to give relative luminescence for each sample expressed in arbitrary units (A/U).
VEGF ELISA
Secreted VEGF was detected using the Human VEGF Quantikine ELISA Kit (R&D Systems, UK).
Conditioned media was collected from cells treated for 24 hours with the TGF-beta type I receptor inhibitor, SD-208 (2 µM) or DMSO vehicle control. VEGF levels were compared to a standard curve of recombinant VEGF.
Zebrafish embryo xenograft studies
EB3K cells stained with CMTMR (Invitrogen, UK) were injected into the yolk sac of 24-hour-old transgenic fli1:EGFP (enhanced green fluorescent protein) embryos as described in the Supplementary Methods, available online.
Statistical methods
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All statistical tests were two sided. P<0.05 was considered statistically significant, student's t-test was used for two variables analysis. Surprisingly, we observed that shCOL7 xenografts were pinker with an increased number of tortuous blood vessels (BV) entering the gel 6 weeks post-implantation, compared with shC or shCOL4 xenografts ( Figure 1A ). Hematoxylin and Eosin staining demonstrated that shCOL7 cells displayed increased invasion. Involucrin and Keratin 10 staining were reduced in shCOL7, but not in shCOL4 xenografts, suggesting loss of Col7 reduces differentiation (Supplementary Figure   2B , available online).
RESULTS
Loss of Col7 enhances angiogenesis
Immunostaining using Meca-32, a murine endothelial cell marker, demonstrated that shCOL7 xenografts were more vascular than shC and shCOL4 ( Figures 1B and 1C (Figure 2A and 2B). Interestingly, RDEB patient scarred skin was also more vascular than normal skin (mean BV number, RDEB skin: 121, SD=21; non-EB skin: 40, SD=7; P<0.001) (Figure 2C and D; n=8 of each).
Loss of Col7 increases epithelial VEGF expression
To assess whether BV formation was promoted directly by SCC shCOL7 cells, we performed an endothelial tube formation assay in vitro using HUVEC cells. suggesting a possible role for secreted growth factors ( Figure 3A and B). An angiogenesis proteome array identified possible angiogenic factors in shCOL7 cells, including VEGF, confirmed by qRTPCR ( Figure 3C and Supplementary Figure 3A , available online).
Immunostaining showed that VEGF expression was markedly increased in RDEB SCC epithelium, as well as at the invasive front in shCOL7 xenografts, which may explain increased angiogenesis in the context of loss of Col7 ( Figure 3D and Supplementary Figure 3B- Figure 4C and Supplementary Figure 3E and F, available online).
Interruption of the Col7-21 integrin interaction enhances TGFsignalling
Type VII collagen binds to the 21 integrin on human dermal fibroblasts [30] . The 2 integrin receptor is expressed on the surface of cutaneous SCC cells ( Figure 5A ) and an adhesion assay demonstrated that an 2-neutralizing antibody reduced RDEB SCC adhesion to hrCol7 by 50% suggesting a direct role in cell attachment to Col7 (relative cell adhesion normalized to BSA-2
Integrin, hrCol7-2 Integrin: 54%, SD=7.4%, P=0.006; Col4-2 Integrin: 66%, SD=6.6%;
P<0.001) ( Figure 5B and Supplementary Figure 4D , available online). Adhesion to hrCol7, but not BSA or Col4 reduced expression of p-Smad2 and v6 integrin and kindlin 2, known components of the TGFsignaling pathway in RDEB SCC ( Figure 5C and Supplementary Figure   4D , available online) [31] . No change was observed in TR11 expression. Blocking the 2 integrin increased p-Smad2 and v6 integrin expression on hrCol7 but not on BSA or Col4.
Similar changes were demonstrated in a SBE luciferase reporter assay ( Figure 5D ). Increased SBE luciferase activity was also observed in shCol7 cells compared to shC with or without TGF, the 10 latter due to a response to autocrine TGF (luciferase luminescence normalized to renilla control, Figure 5E ). TGFB1 mRNA expression decreased 1.7-fold in RDEB SCC cells plated on hrCol7 compared to BSA. Blocking 2 integrin increased TGFB1 expression 1.8-fold on hrCol7 but not BSA ( Figure 5F ). These data suggest that binding of Col7 to the 2 integrin in SCC keratinocytes downregulates TGF signaling, a known regulator of cell invasion, EMT and angiogenesis.
TGFsignaling is enhanced in shCOL7 SCC cells and RDEB tumors
Analysis Finally, TGF- driven nuclear Smad4 signaling is a known mediator of angiogenesis [34, 35] .
Immunostaining of ShC xenografts showed intense cytoplasmic staining and some nuclear staining of Smad4. In contrast, in shCOL7 xenografts, there was less cytoplasmic Smad4 and nuclear Smad4 was present at the invading edge of the tumor. Injection of hrCOL7 restored cytoplasmic > nuclear Smad4 throughout the tumor ( Figure 7D ). Immunostaining of RDEB and non-EB SCC tumors showed increased nuclear Smad4 in RDEB tumor sections ( Figure 7E ) consistent with our hypothesis that loss of Col7 is driving TGF- induced angiogenesis in RDEB. Renilla was used as an internal transfection control Statistical analysis was performed using twotailed t tests. *, ** and *** = P < 0.05, P<0.01 and P<0.001, respectively. 
Supplementary Table 1. Antibodies table.
Supplementary Table 2 . shRNA clones and their target sequences, qPCR primers and their sequences, TGFBR1and TGFBR2 ON-TARGET siRNA sequences. Table 3 . RDEB and non-EB SCC tumor samples.
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Supplementary Methods
Cell culture
The human non-RDEB cutaneous SCC keratinocyte cell line SCC-IC1 [1] , and the RDEB (severe generalized) SCC keratinocyte cell lines EB3K [1, 2] , were cultured in DMEM:Ham's F12 (3:1) supplemented with 10% FCS, 1% L-glutamine (200 mM) and RM Plus (0.4 g/ml hydrocortisone, 5 g/ml insulin, 10 ng/ml EGF, 5 g/ml transferrin, 8.4 ng/ml cholera toxin, and 13 ng/ml liothyronine). Human foreskin fibroblasts (HF) were cultured in DMEM supplemented with 10% FCS and 1% L-glutamine (200 mM). All cells were cultured at 37°C and 5% CO2. All cell lines were derived from primary cutaneous invasive SCCs and spontaneously immortalized in culture.
Generation of shRNA-transduced cell lines
For stable knock-down of type IV and type VII collagens in cutaneous SCC, the SCC-IC1 cell line was transduced with SMARTvector™ lentiviral particles (ThermoFisher Scientific, UK) of three different shRNA clones targeting either collagen (Supplementary Table 2 ) as well as non-targeting particles (negative control). SCC-IC1 cells, seeded at 50% confluency, were incubated overnight with viral particles at a MOI (multiplicity of infection) of 2 diluted in complete DMEM:Ham's F12 media supplemented with polybrene (5 g/ml). Transduced cells were selected in puromycin (2.5 g/ml) 48 hours after.
Protein analysis
For cell lysate immunoblot analysis, keratinocytes were lysed in 1x Triton-lysis buffer (20 mM Tris pH 7.4, 137 mM NaCl, 2 mM EDTA pH 7.4, 1% Triton X-100, 10% glycerol and 1mM Na3VO4) supplemented with a protease-inhibitor-cocktail (Roche, UK) and 10 mM EDTA. For type IV and type VII collagen analyses, reduced cell extracts were subjected to 6% SDS-PAGE. Otherwise, lysates were subjected to 8% or 10% SDS-PAGE. The presence of protein was detected by WB analysis using a primary antibody at 4°C overnight, and a HRP-coupled anti-mouse or -rabbit secondary antibody for 1 hour at room temperature and developed using Enhanced Chemo Luminescence. For densitometry analysis, the image analysis program "Image J, v. 1.34s" was used.
qRTPCR
RNA extraction was performed using the RNeasy mini kit (Qiagen, UK) according to the manufacturer's instructions. cDNA was generated using the SuperScript® VILO™ cDNA Synthesis kit (Invitrogen, UK). qPCR was carried out using KAPA SYBR® Universal qPCR Mastermix (Anachem, UK) on a ABI Prism® 7500 (ABI, UK). Primer sequences are shown in Supplementary Table 2.
Fluorescence and DAB immunostaining
Archival skin sections were obtained of formalin-fixed and paraffin-embedded human RDEB and non-EB SCCs (Supplementary Table 3 , available online). Tumors were graded using the Broder's classification system [3] . Tissue microarray blocks were generated previously from RDEB and non-EB SCC [4] . Five m-thick paraffin sections of 4% paraformaldehyde (PFA)-fixed and paraffin-embedded organotypic cultures were cut using a microtome, and air-dried at room temperature overnight. Cryosections (5 m-thick) from organotypic cultures were cut in a cryostat, air-dried and fixed in acetone:methanol at -20ºC for 20 minute before staining. Paraffin sections were de-paraffinized using xylene, hydrated in descending grades of ethanol to distilled water, and antigen retrieval was performed by heating samples in boiling 10 mM citrate buffer, pH 6.0, for 10 minutes. Immunofluorescence staining was performed as follows: sections from organotypic cultures or patient skin were blocked at room temperature by incubating in 1% BSA for 30 minutes. Incubation with the primary antibody diluted in 0.3% BSA was performed at 4°C overnight. The secondary Alexa Fluor 568-red or 488-green, goat anti-rabbit, goat anti-mouse, donkey anti-goat, donkey anti-rat or goat anti-chicken (Invitrogen, UK), antibodies were added at a 1:800 dilution for 45 minutes at room temperature. DAPI (300nM) was used as a nuclear stain. For DAB (diaminobenzidine) immunostaining, paraffin sections were de-paraffinized as described above and the VECTASTAIN Universal Quick R.T.U. Kit used (VECTOR Laboratories, UK). Visualization was performed using DAB (DakoCytomation, UK) and nuclei counterstained using Meyer's Hematoxylin. Images were photographed using a Leica DM5000B fluorescence (Leica Germany), a Zeiss LSM 510s confocal (Zeiss Germany) or a Nikon Eclipse 80i microscope. Images were analyzed using ImageJ and CellProfiler 2.11 software.
In vitro epidermal models
Collagen:matrigel gels were prepared by mixing 4.9 volumes of type I collagen (BD Biosciences, UK), 2.1 volumes of Matrigel (BD Biosciences, UK), 1 volume of 10x DMEM, 1 volume of FCS, and 1 volume of DMEM/10% FCS/HF (resuspended at a density of 5x10 6 /ml). Gels were incubated for 24 hours to equilibrate and, after that keratinocytes (shC SCC-IC1, shCOL7 SCC-IC1 and shCOL4 SCC-IC1) were seeded on the top of the gel at a density of 5x10 5 per gel. After 24 hours, gels were raised to the air-liquid interface on stainless steel grids. The gels were harvested 10 days after, fixed in 4% PFA and embedded in paraffin. The TGF-beta type I receptor inhibitor, SD-208, was added to the media at a concentration of 2 µM and media replaced every other day. DMSO at the same concentration was used as a vehicle control. The gels were harvested at day 8 -10, fixed in 4% PFA and embedded in paraffin.
Cell invasion assay
Depth of keratinocyte invasion into collagen:matrigel gels was assessed using Hematoxylin and Eosin stained sections. Paraffin sections were de-paraffinized using xylene, hydrated in descending grades of ethanol to distilled water, stained in Hematoxylin (Gill's 1x) and Eosin, and dehydrated in ascending grades of ethanol to xylene. Sections were examined and photographed using a Nikon Eclipse 80i microscope. Cell invasion into collagen:matrigel gels was quantified using a modification of the "Invasion Index" from Nystrom et al [5] . 
Blood vessel quantification
For blood vessel quantification in shC, shCOL7 and shCOL4 SCC-IC1 xenografts, sections were stained with a Meca-32 antibody as described above. A total of 45 sections were quantified (three images per section were taken with a total of 3 non-adjacent sections used per replicate). Images were analyzed using a CellProfiler (www.cellprofiler.org) analysis pathway specifically written for this analysis. Blood vessels were identified by Meca-32 staining, outlined, and both vessel number and size recorded. Mean vessel number and area were compared between shC, shCOL7 and shCOL4 SCC-IC1 samples using a two-tailed Student t-test.
In vitro HUVEC tube formation assay
Matrigel (50ul) 
Cell adhesion assay
For assessment of cell attachment to hrCol7, 24-well plates were coated with 10 g/ml of hrCol7, Col4 or BSA in 20 mM carbonate buffer, pH 9.3, at room temperature overnight.
EB3K cells were incubated either with an 2 inhibiting antibody (50 ug/ml) or control IgG GAPDH was used as an internal control of protein loading. Gel cut to remove irrelevant wells. For densitometric analysis, results were normalized to GAPDH and are expressed as fold induction over BSA-IgG. (E) qRTPCR analysis of TGFBR1 expression in siRNA knock-down of TRI and TRII using a specific for TRI (siTRI) or TRII (siTRII), A double knock-down (siTRI+II) was also performed. . Results are shown as mean ± s.d. ** and *** indicate P < 0.01 and P<0.001, respectively. (F) qRTPCR analysis of TGFBR2 expression in siRNA knock-down of TRI and TRII using a specific for TRI (siTRI) or TRII (siTRII), A double knock-down (siTRI+II) was also performed. Results are shown as mean ± s.d. ** and *** indicate P < 0.01 and P<0.001, respectively. (G) Western blotting analysis of p-SMAD2, total SMAD2 and SMAD4 in shC and shCOL7 cells plated on BSA or hrCol7 in complete media (with serum). GAPDH was used as an internal control of protein loading. Gel cut to remove irrelevant wells. For densitometric analysis, results were normalized to GAPDH and are expressed as fold induction over BSA shC. The scale bars represent 100 µm in (A) and 20µm in (B)
